2nd Quarter - Report

CARIS LIFE SCIENCES, INC. for CARIS LIFE SCIENCES, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$52,121
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 20, 2012 $52,121 Replaced
2nd Quarter - Amendment Jul 27, 2012 $52,121 Replaced
2nd Quarter - Amendment Jul 27, 2012 $52,121 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.

LobbyistCovered position, as disclosed
AMY JENSEN CUNNIFFE Asst. to the Speaker of the House for Policy

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 3765 (112th), H.R. 2461 (112th), H.R. 3207 (112th), H.R. 3630 (112th)

Medicare/Medicaid MMM

Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.

LobbyistCovered position, as disclosed
AMY JENSEN CUNNIFFE Asst. to the Speaker of the House for Policy

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA)

Bills named: H.R. 3630 (112th), H.R. 3207 (112th), H.R. 3765 (112th), H.R. 2461 (112th)

Insurance INS

Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.

LobbyistCovered position, as disclosed
AMY JENSEN CUNNIFFE Asst. to the Speaker of the House for Policy

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3630 (112th), H.R. 3207 (112th), H.R. 2461 (112th), H.R. 3765 (112th)

Medical/Disease Research/Clinical Labs MED

Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.

LobbyistCovered position, as disclosed
AMY JENSEN CUNNIFFE Asst. to Speaker of the House for Policy

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3630 (112th), H.R. 2461 (112th), H.R. 3765 (112th), H.R. 3207 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.